Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight ...

This story has been updated to include a link to a related podcast from The Dallas Morning News on the topic of GLP-1s. When Trova Wine and Market shut its doors last month after nearly five years ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

Eli Lilly (LLY, Financial) is set to pivot its focus beyond obesity after a monumental windfall from its GLP-1 drugs. At its ...

CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market GrowsSCHAUMBURG, IL, Feb. 20, 2025 ...